New Actos Bladder Cancer Lawsuit Moves Forward

Latest Actos Bladder Cancer Lawsuit Alleges Negligence and Misrepresentation

Actos bladder cancerThe latest Actos bladder cancer personal injury lawsuit is moving forward in MDL 2299, in the US District Court of Western Louisiana.

Plaintiff Walter Rosenblum’s Actos lawsuit was filed on September 19th, 2013. According to the filing, Rosenblum was prescribed Actos to treat his Type 2 diabetes in March 2006, and he took it until September 2010. In July 2012, Rosenblum was diagnosed with bladder cancer, and he alleges that it was a direct result of taking Actos for more than two years.

Previous studies have shown that taking Actos for more than two years increases the patient’s likelihood of developing bladder cancer.

Because Rosenblum’s bladder cancer was in stage 2 when he was finally diagnosed, his bladder had to be removed, and he has had a host of medical procedures since then.

The Actos personal injury suit says that at no time while he took Actos was the plaintiff aware that he may develop bladder cancer. The filing says that Rosenblum and other patients rely on the good faith of labels, as well as the medical information that is available to their physicians. Takeda Pharmaceuticals, the defendant company in the Actos MDL, made no effort to inform patients or physicians of the potential link to Actos bladder cancer until independent studies began uncovering the problem.

Rosenblum is suing Takeda and its US subsidiary Eli Lilly for negligence, misrepresentation of a product, false advertising, and concealing information.

Currently, Takeda Pharmaceuticals, the manufacturer of controversial Type 2 diabetes drug Actos, faces more than 3,000 personal injury and wrongful death lawsuits, linking the drug to the development of bladder cancer in those patients that ingested Actos for two years or more. About 1,200 of the lawsuits have been consolidated into a multidistrict litigation (MDL) in Louisiana.

Actos Linked to Serious Personal Injury

The FDA is currently investigating the risks of taking Actos, and says their review will wrap up next year. Based on evidence from new studies, the government agency issued a warning against Actos and said Takeda had to package their drug with the strongest possible warning label. Meanwhile, both France and Germany banned the drug from sale in their countries, and most recently, India temporarily banned Actos and the generic form pioglitazone, but after confrontations with doctors, rescinded the ban pending further study.

There are several side effects associated with Actos.  You should seek medical attention if you experience:

  • shortness of breath or trouble breathing,
  • chest pain,
  • extreme fatigue,
  • irregular heartbeat,
  • dilated neck veins,
  • swelling of face, fingers, feet, or lower legs,
  • decreased urine output, and
  • weight gain

The Strom Law Firm Can Help with Personal Injury and Wrongful Death Cases, Including Against Actos

If you or a loved one have taken Actos to treat Type 2 diabetes, and have since suffered dangerous side effects including developing bladder cancer, heart disease, liver failure, or diabetic macular edema, you may be entitled to compensation. The attorneys at the Strom Law Firm can help with personal injury cases, including against Actos manufacturer Takeda Pharmaceuticals. We offer free, confidential consultations to discuss the facts of your case, so do not hesitate to contact us803.252.4800

About Pete Strom

Defending criminal charges including drug crimes, DUI, CDV, mail fraud, wire fraud, bank fraud, computer crimes, money laundering, and juvenile crimes, Pete also handles Federal and State investigations. Representing individuals in Civil Matters including Class Actions, Personal Injury, Qui Tam Actions, Defective Products, Nursing Home Neglect, and Professional Licensing Defense cases. Joseph Preston “Pete” Strom, Jr., the managing partner at Strom Law Firm, L.L.C., has been fighting for justice since 1984.

Leave a Reply

BestLawyers.comAVBetter Business Bureau